Cardiovascular — Genetic Risk

Lipoprotein(a) — Lp(a)

Lp(a) is a genetically-determined atherogenic lipoprotein that should be measured at least once in life.

Reference range

Optimization target: <50 mg/dL or <75 nmol/L. Functional optimization context only — not a diagnostic assertion. Range varies by lab, age, and sex.

Why it matters

Lp(a) is the single most important once-in-a-lifetime cardiovascular marker. It is genetically determined, largely unaffected by diet or exercise, and an independent driver of atherosclerotic risk. Every adult should have it measured at least once. REVRCEL includes Lp(a) in baseline bloodwork so the rest of the cardiovascular optimization plan is built with that risk anchor in view.

How REVRCEL clinicians read it

Lp(a) does not need to be repeated regularly; it is largely stable through life. Risk-stratifies the rest of the cardiovascular plan.

Included in

Common questions

Should I test Lp(a)?

At least once, yes. It is a genetic risk marker every adult should know.

Can I lower Lp(a)?

Lifestyle has limited effect. Specific therapies are emerging. Knowing the value changes how aggressively other risk factors are managed.

Related biomarkers

ApoB (Apolipoprotein B)hs-CRP (High-Sensitivity C-Reactive Protein)

Statements have not been evaluated by the FDA. This page is educational and is not medical advice.